Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04778579
Title Study of the Infusion of ARI-0001 Cells in Patients With CD19 + Acute Lymphoid Leukemia Resistant or Refractory to Therapy (CART19-BE-02)
Acronym CART19-BE-02
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sara V. Latorre
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP


No variant requirements are available.